Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Treatment of Adults With Primary Malignant Glioma With Topotecan (NSC #609699) Plus BCNU (NSC #409962)

NCT00002986 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT00002986
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00002986 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Treatment of Adults With Primary Malignant Glioma With Topotecan (NSC #609699) Plus BCNU (NSC #409962)
Lead sponsor
Duke University
Phase
Phase 1
Overall status
Completed
Start date
February 28, 1997
Completion date
May 31, 2004
Enrollment
36 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

brain and central nervous system tumors